Keywords: nexium/prilosec, under, review, canada, usa, after, being
Nexium/Prilosec under review in Canada and USA after being linked to cardiac AEs
Article | 20 August 2007
The US and Canadian drug regulators are reviewing new preliminary safety information regarding serious cardiac events in patients using Anglo-Swedish ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
